Home|Journals|Articles by Year|Audio Abstracts

Original Research

J. res. tradit. med. 2016; 2(2): 34-38

Pharmacognostical Evaluation of Benincasa Hispida (thunb.) Cogn. (Kushmanda) Fruit

Shivanand T Biradar*, Harisha C R, Galib R, Prajapati P K.


Background: Benincasa hispida (Thunb.) Cogn. belongs to the genus Benincasa and family Cucurbitaceae which is known as Kushmanda in Ayurveda. Reports of pharmacognostical study of seed are available however there is no published report on fresh fruit of Kushmanda till date. Considering which, the present study is planned. Aims: To record macroscopic and microscopic evaluation of fresh fruit and powder microscopy of Benincasa hispida. Materials & Methods: Fresh fruit of was collected from local market of Jamnagar and authenticated. Standard procedures were followed to undertake the pharmacological evaluation and basic physico-chemical analysis. Results: Fresh fruit showed presence of stone cells, vascular bundles, prismatic crystals, lignied stone cells, lignied pitted parenchyma. Powder microscopy showed annular vessels, oil globules, starch granules, simple bers, tannin containing cells and calcium carbonate. Conclusion: As there are no reported study on the whole fruit of Kushmanada, the results obtained from study might help as reference guidance for future scientic evaluations of the drug.

Key words: Benincasa hispida, Kushmanda, Fruit, Pharmacognosy

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.